Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Manulife Financial Corporation (MFC) vs GeneDx Holdings Corp (WGS) Price & Performance

Manulife Financial CorporationTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Manulife Financial Corporation vs GeneDx Holdings Corp — how do they compare? Manulife Financial Corporation trades at $42.51 (market cap $69.96B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Manulife Financial Corporation is far larger — about 38.9× GeneDx Holdings Corp's market cap, and Manulife Financial Corporation pays a 3.14% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

MFCWGS
Market Cap
$69.96B$1.80B
Sector
FinancialsTechnology
52-Week High
$43.39$167.51
52-Week Low
$29.90$34.51
Enterprise Value
$66.52B$1.80B
Dividend Yield
3.14%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Manulife Financial Corporation

MFC trades at $42.83, down 1.29% today, with a bullish technical signal supported by moving averages. The company reported revenue of $53.01B in 2025 and net income of $5.78B, with a P/E of 17.39. Recent news highlights AI advancements and strong Asia performance, while Q1 2026 earnings missed expectations. Analyst consensus is 57% buy with no sell ratings.

Outlook remains positive driven by AI initiatives and Asia growth, but risks include Q1 earnings miss and regulatory scrutiny. The stock offers steady profitability and dividend income, yet faces headwinds from wealth management outflows and competitive pressures in core markets.

GeneDx Holdings Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Manulife Financial Corporation

Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.

Read more on MFC

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS